Bionime Corporation (TPE:4737)
Taiwan · Delayed Price · Currency is TWD 57.10
-2.80 (-4.67%)
May 29, 2026, 1:30 PM CST
Bionime Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -247.64 | -180.28 | -127.22 | 6.21 | 91.03 | 87.41 |
Depreciation & Amortization | 164.19 | 164.85 | 166.12 | 151.33 | 142.16 | 143.77 |
Other Amortization | 17.43 | 17.43 | 16.68 | 12.1 | 11.07 | 10.89 |
Loss (Gain) From Sale of Assets | 3.12 | 3.07 | 0.08 | 0.01 | 4.17 | 0 |
Asset Writedown & Restructuring Costs | 9.45 | 9.45 | 3.98 | - | - | - |
Loss (Gain) From Sale of Investments | - | - | - | - | 0.01 | - |
Stock-Based Compensation | 22.68 | 19.48 | 13.48 | 4.78 | 7.85 | 12.77 |
Provision & Write-off of Bad Debts | 4.73 | -5.89 | 26.14 | -36.51 | 29.59 | -20.56 |
Other Operating Activities | -26.63 | -24.84 | -58.98 | -39.21 | -5.09 | -2.23 |
Change in Accounts Receivable | 99.55 | 147.56 | -177.68 | 204.31 | -354.55 | 101.49 |
Change in Inventory | 116.01 | 108.73 | -79.89 | 47.18 | 49.77 | -71.55 |
Change in Accounts Payable | -7.07 | -49.77 | 43.72 | -31.51 | 28.06 | 4.82 |
Change in Other Net Operating Assets | 196.35 | 285.01 | 193.1 | -115.23 | 138.22 | 2.91 |
Operating Cash Flow | 352.16 | 494.8 | 19.53 | 203.44 | 142.29 | 269.72 |
Operating Cash Flow Growth | 225.69% | 2433.55% | -90.40% | 42.98% | -47.24% | 23.98% |
Capital Expenditures | -119.38 | -156.18 | -186.08 | -293.08 | -137.68 | -137.48 |
Sale of Property, Plant & Equipment | - | - | 0.01 | - | 4.49 | - |
Sale (Purchase) of Intangibles | -134.07 | -132.22 | -146.74 | -148.32 | -175.25 | -147.09 |
Investment in Securities | 2.53 | -0.52 | -3.97 | 6 | -3.56 | -3.78 |
Other Investing Activities | 2.84 | 2.85 | -0.12 | 0.14 | -0.26 | 0.27 |
Investing Cash Flow | -248.07 | -286.07 | -336.9 | -435.26 | -312.26 | -288.07 |
Short-Term Debt Issued | - | 2,138 | 3,483 | 3,177 | 3,458 | 1,663 |
Long-Term Debt Issued | - | 1,000 | 600 | 1,200 | 1,000 | 500 |
Total Debt Issued | 2,815 | 3,138 | 4,083 | 4,377 | 4,458 | 2,163 |
Short-Term Debt Repaid | - | -2,634 | -3,037 | -3,013 | -3,617 | -1,679 |
Long-Term Debt Repaid | - | -619.61 | -713.6 | -825.49 | -615.72 | -460.1 |
Total Debt Repaid | -3,376 | -3,254 | -3,750 | -3,838 | -4,233 | -2,139 |
Net Debt Issued (Repaid) | -561.08 | -115.68 | 332.43 | 538.71 | 225.59 | 23.87 |
Issuance of Common Stock | 505.32 | 5.38 | 6.93 | 10.46 | 9.32 | 30.56 |
Common Dividends Paid | - | - | -122 | -127.69 | -121.2 | -124.28 |
Other Financing Activities | 1.8 | 1.78 | -0.06 | -1.08 | -0.07 | 0.56 |
Financing Cash Flow | -53.96 | -108.53 | 217.3 | 420.41 | 113.64 | -69.3 |
Foreign Exchange Rate Adjustments | -2.55 | 1.7 | 29.48 | -11.26 | 17.73 | -2.52 |
Net Cash Flow | 47.58 | 101.9 | -70.59 | 177.33 | -38.6 | -90.16 |
Free Cash Flow | 232.79 | 338.62 | -166.55 | -89.64 | 4.62 | 132.25 |
Free Cash Flow Growth | - | - | - | - | -96.51% | 49.80% |
Free Cash Flow Margin | 13.21% | 18.42% | -8.61% | -5.11% | 0.21% | 7.15% |
Free Cash Flow Per Share | 3.37 | 5.04 | -2.48 | -1.33 | 0.07 | 1.98 |
Cash Interest Paid | 65.71 | 65.71 | 60.49 | 47.97 | 29.46 | 18.86 |
Cash Income Tax Paid | - | -1.25 | 2.11 | 1.4 | 1.86 | -10.23 |
Levered Free Cash Flow | 71.68 | 227.77 | -262.26 | -263.23 | -194.16 | -52.71 |
Unlevered Free Cash Flow | 111.59 | 268.34 | -223.39 | -233.08 | -175 | -40.81 |
Change in Working Capital | 404.84 | 491.53 | -20.74 | 104.75 | -138.5 | 37.67 |